SCHEMBL5059068

SCHEMBL5059068

CCOC(=O)c1ccc(C(=O)NC(C)CO)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 5/20 0.50
TAS1R1 Q7RTX1 5/20 0.50
HPGD P15428 2/20 0.47
ALDH1A1 P00352 1/20 0.47
GAA P10253 1/20 0.47
GRN P28799 1/20 0.44
SORT1 Q99523 1/20 0.44
TP53 P04637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.42
CYP4F2 P78329 1/20 0.41
CYP4A11 Q02928 1/20 0.41
BAZ2B Q9UIF8 1/20 0.41
BAZ2A Q9UIF9 1/20 0.41
KDM4E B2RXH2 1/20 0.41
KMT2A Q03164 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
S1PR1 P21453 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5063207 0.84 NPSR1 (0.44) TAS1R3TAS1R1HPGDALDH1A1GAA
SCHEMBL5059057 0.80 HPGD (0.52) HPGDALDH1A1GAANPSR1CYP4F2
SCHEMBL14627779 0.80 GRN (0.61) TAS1R3TAS1R1HPGDALDH1A1GAA
SCHEMBL13754417 0.80 GRN (0.61) TAS1R3TAS1R1HPGDALDH1A1GAA
SCHEMBL1760466 0.79 CA12 (0.57) ALDH1A1CYP4F2CYP4A11BAZ2BBAZ2A
SCHEMBL9668165 0.77 HPGD (0.51) TAS1R3TAS1R1HPGDALDH1A1GAA
SCHEMBL5063384 0.77 HPGD (0.44) HPGDALDH1A1GAATP53CYP4F2
SCHEMBL5063269 0.77 LMNA (0.52) ALDH1A1CYP4F2CYP4A11BAZ2BBAZ2A
SCHEMBL17158197 0.75 TAS1R3 (0.52) TAS1R3TAS1R1HPGDALDH1A1GAA
SCHEMBL1480000 0.74 RAB9A (0.46) ALDH1A1KDM4EKMT2ACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161294-A1 Urea derivative, medicinal composition containing the same, and medicinal use of these KISSEI PHARMACEUTICAL CO., LTD. (JP) 2008-07-03 US disclosed
EP-1867639-A1 UREA DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2007-12-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161294-A1 Urea derivative, medicinal composition containing the same, and medicinal use of these AVPR2, UTS2R, GPR119 TAS1R3 1234/4885TAS1R1 1121/4885HPGD 599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.